| Name | Title | Contact Details |
|---|
Climb Bio, Inc. is a clinical-stage biotechnology company based in Wellesley Hills, Massachusetts. Founded in 2018 and formerly known as Eliem Therapeutics, Climb Bio focuses on developing innovative therapies for immune-mediated diseases. The company emphasizes building strong relationships to gain insights and create effective medicines aimed at improving the quality of life for patients. Climb Bios product pipeline includes Budoprutug, an anti-CD19 monoclonal antibody in various stages of development for B-cell mediated diseases, and CLYM116, an anti-APRIL monoclonal antibody in preclinical development for IgA Nephropathy. The company is committed to advancing life sciences through innovative research and clinical trials, with a dedicated team led by CEO Aoife Brennan.
Tohnichi America Corporation is a Northbrook, IL-based company in the Business Services sector.
A and A Tours Inc is a San Juan, PR-based company in the Business Services sector.
Isolation Concept Isobloc is a Magog, QC-based company in the Business Services sector.
Noble Royalties is a Addison, TX-based company in the Business Services sector.